Pharmacists interviewed by SN differ over whether the Food and Drug Administration will actually recall Seldane, a widely prescribed antihistamine, because of rare, but potentially deadly side effects. The FDA announced Jan. 13 that it was proposing to recall Seldane, which it said can cause fatal heart-rhythm abnormalities, particularly when it is taken with erythromycin and ketoconazole. Seldane, a product of Hoechst Marion Roussel, Kansas City, Mo., was marketed in 1985 as the first ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.